Search Results - "Duarte, Cassandra"

Sexual and gender minority health in medical curricula in new England: a pilot study of medical student comfort, competence and perception of curricula by Zelin, Nicole Sitkin, Hastings, Charlotte, Beaulieu-Jones, Brendin R., Scott, Caroline, Rodriguez-Villa, Ana, Duarte, Cassandra, Calahan, Christopher, Adami, Alexander J.

“…Background: Sexual and gender minority (SGM) individuals experience high rates of harassment and discrimination when seeking healthcare, which contributes to…”
Get full text

Bringing Home the Bacon by Duarte, Cassandra

Get full text

Spontaneous regression of an extragonadal seminomatous germ cell tumor by Duarte, Cassandra, Gilbert, Danielle M., Sheridan, Alison D., La Rosa, Francisco G., McCarter, Martin, Cost, Nicholas G., Emmons, Steven, Lam, Elaine T.

“…•Primary extragonadal germ cell tumors (GCT) are a unique entity.•Spontaneous regression of malignancy is a rare phenomenon possibly mediated by immune-induced…”
Get full text

Blood in the Duodenum by Duarte, Cassandra, Li, Nanxing

Get full text

Management Considerations for Patients With Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma by Duarte, Cassandra, Kamdar, Manali

“…Most patients with diffuse large B-cell lymphoma (DLBCL) will be cured with up-front chemoimmunotherapy, but 30%-40% of patients will experience relapsed…”
Get full text

Hereditary cancer screening at an urban safety net hospital by Brehany, Sydney, Colton, Meryl D., Duarte, Cassandra, Baliton, Michael, Okuyama Sasaki, Sonia

“…10604 Background: Individuals with hereditary cancer syndromes (HCS) have a high lifetime risk of developing cancer. However, the rate at which at-risk…”
Get full text

Socioeconomic Status Is a Mediator of Overall Survival in Acute Myeloid Leukemia (AML) by Duarte, Cassandra, Abbott, Diana, Bosma, Grace N, McMahon, Christine M., Gutman, Jonathan A, Schwartz, Marc, Pollyea, Daniel, Amaya, Maria L

“…Introduction: AML is a morbid disease with a five-year overall survival (OS) rate of 30.5%. Despite increasing treatment options and improved OS, inequities…”
Get full text

A Qualitative Study Comparing the Patient and Provider Experience in an Academic Blood Disorder Center by Tolison, Hunter, Duarte, Cassandra, Peterson, Glen, Bosma, Grace N, Abbott, Diana, George, Gemlyn, Pollyea, Daniel, Jordan, Craig T., Amaya, Maria L

“…Introduction: Health disparities have been reported in several areas of hematologic and oncologic care. The NCI reports African American males develop cancer…”
Get full text

Hereditary Cancer Screening and Outcomes at an Urban Safety-Net Hospital by Brehany, Sydney, Colton, Meryl, Duarte, Cassandra, Baliton, Michael, McCranie, Alec S, Okuyama, Sonia

“…Patients with hereditary cancer syndromes (HCS) have a high lifetime risk of developing cancer. Historically underserved populations have lower rates of…”
Get more information

Outcomes in Patients with Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers by Voorhees, Timothy, McLaughlin, Eric, Torka, Pallawi, Florindez, Jorge A, Moyo, Tamara K., Reves, Heather, Sumransub, Nuttavut, Deshpande, Saarang, Rose, Ashley, Duarte, Cassandra, Faisal, Muhammad Salman, Hamid, Showkat, Subbiah, Suki, Ayyappan, Sabarish R., Shea, Lauren Kelly, Cortese, Matthew J, Patel, Krish, Major, Ajay, Saeed, Hayder, Svoboda, Jakub, Desai, Sanjal H., Ramakrishnan Geethakumari, Praveen, Grover, Natalie S., Epperla, Narendranath

“…Background: Brentuximab vedotin (BV) and anti-PD-1 therapies (nivolumab and pembrolizumab) have changed the therapeutic landscape for patients (pts) with…”
Get full text

Allogeneic Stem Cell Transplant and CD30 Directed CART Cell Therapies Are Associated with Improved Survival in Classical Hodgkin Lymphoma Refractory or Intolerant to Brentuximab Vedotin and Anti-PD-1 Therapy: Real World Analysis from 14 U.S. Academic Centers by Voorhees, Timothy, Grover, Natalie S., McLaughlin, Eric, Florindez, Jorge A, Moyo, Tamara K., Reves, Heather, Sumransub, Nuttavut, Deshpande, Saarang, Rose, Ashley, Duarte, Cassandra, Faisal, Muhammad Salman, Hamid, Showkat, Subbiah, Suki, Ayyappan, Sabarish R., Shea, Lauren Kelly, Cortese, Matthew J, Patel, Krish, Major, Ajay, Saeed, Hayder, Svoboda, Jakub, Desai, Sanjal H., Ramakrishnan Geethakumari, Praveen, Torka, Pallawi, Epperla, Narendranath

“…Background: Patients (pts) with classical Hodgkin Lymphoma (cHL) who become refractory to both BV and anti-PD-1 therapies (double refractory, DR) or intolerant…”
Get full text

Treatment outcomes in renal cell carcinoma patients with metastases to the pancreas and other sites by Duarte, Cassandra, Beuselinck, Benoit, Weise, Nicole, Dizman, Nazli, Collier, Katharine, Li, Haoran, Martinez Chanza, Nieves, Elias, Roy, Rose, Tracy L, Brugarolas, James, Agarwal, Neeraj, Mortazavi, Amir, Pal, Sumanta K., McKay, Rana R., Hu, Junxiao, Lam, Elaine Tat

“…Abstract only 4557 Background: Metastatic RCC (mRCC) involving the pancreas is distinct from RCC involving other metastatic sites and is characterized by an…”
Get full text

Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia by Stiff, Andrew, Fornerod, Maarten, Kain, Bailee N., Nicolet, Deedra, Kelly, Benjamin J., Miller, Katherine E., Mrózek, Krzysztof, Boateng, Isaiah, Bollas, Audrey, Garfinkle, Elizabeth A. R., Momoh, Omolegho, Fasola, Foluke A., Olawumi, Hannah O., Mencia-Trinchant, Nuria, Kloppers, Jean F., van Marle, Anne-Cecilia, Hu, Eileen, Wijeratne, Saranga, Wheeler, Gregory, Walker, Christopher J., Buss, Jill, Heyrosa, Adrienne, Desai, Helee, Laganson, Andrea, Hamp, Ethan, Abu-Shihab, Yazan, Abaza, Hasan, Kronen, Parker, Sen, Sidharth, Johnstone, Megan E., Quinn, Kate, Wronowski, Ben, Hertlein, Erin, Miles, Linde A., Mims, Alice S., Oakes, Christopher C., Blachly, James S., Larkin, Karilyn T., Mundy-Bosse, Bethany, Carroll, Andrew J., Powell, Bayard L., Kolitz, Jonathan E., Stone, Richard M., Duarte, Cassandra, Abbott, Diana, Amaya, Maria L., Jordan, Craig T., Uy, Geoffrey L., Stock, Wendy, Archer, Kellie J., Paskett, Electra D., Guzman, Monica L., Levine, Ross L., Menghrajani, Kamal, Chakravarty, Debyani, Berger, Michael F., Bottomly, Daniel, McWeeney, Shannon K., Tyner, Jeffrey W., Byrd, John C., Salomonis, Nathan, Grimes, H. Leighton, Mardis, Elaine R., Eisfeld, Ann-Kathrin

“…Genomic profiles and prognostic biomarkers in patients with acute myeloid leukemia (AML) from ancestry-diverse populations are underexplored. We analyzed the…”
Get full text

Outcomes of patients with pancreatic-only oligometastatic renal cell carcinoma (RCC) by Duarte, Cassandra, Martinez Chanza, Nieves, Collier, Katharine, Dizman, Nazli, Rathi, Nityam, McKay, Rana R., Panian, Justine, Narayan, Vivek, Carneiro, Benedito A., Mega, Anthony E., Hu, Junxiao, Meguid, Cheryl, Agarwal, Neeraj, Pal, Sumanta K., Mortazavi, Amir, Harshman, Lauren Christine, Lam, Elaine Tat

“…Abstract only 681 Background: Patients (pts) with RCC and oligometastatic pancreas metastases are treated with pancreatectomy, stereotactic body radiation…”
Get full text

Correlation of Minority Status, Cyberbullying, and Mental Health: A Cross-Sectional Study of 1031 Adolescents by Duarte, Cassandra, Pittman, Sarah K., Thorsen, Margaret M., Cunningham, Rebecca M., Ranney, Megan L.

“…Adolescent cyberbullying is increasingly prevalent. Depression and suicidal ideation are also common, particularly among minority adolescents and cyberbullied…”
Get full text

Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective study by Duarte, Cassandra, Hu, Junxiao, Beuselinck, Benoit, Panian, Justine, Weise, Nicole, Dizman, Nazli, Collier, Katharine A., Rathi, Nityam, Li, Haoran, Elias, Roy, Martinez-Chanza, Nieves, Rose, Tracy L., Harshman, Lauren C., Gopalakrishnan, Dharmesh, Vaishampayan, Ulka, Zakharia, Yousef, Narayan, Vivek, Carneiro, Benedito A., Mega, Anthony, Singla, Nirmish, Meguid, Cheryl, George, Saby, Brugarolas, James, Agarwal, Neeraj, Mortazavi, Amir, Pal, Sumanta, McKay, Rana R., Lam, Elaine T.

“…Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine organs…”
Get full text

Metastatic renal cell carcinoma to the pancreas and other sites—a multicenter retrospective studyResearch in context by Cassandra Duarte, Junxiao Hu, Benoit Beuselinck, Justine Panian, Nicole Weise, Nazli Dizman, Katharine A. Collier, Nityam Rathi, Haoran Li, Roy Elias, Nieves Martinez-Chanza, Tracy L. Rose, Lauren C. Harshman, Dharmesh Gopalakrishnan, Ulka Vaishampayan, Yousef Zakharia, Vivek Narayan, Benedito A. Carneiro, Anthony Mega, Nirmish Singla, Cheryl Meguid, Saby George, James Brugarolas, Neeraj Agarwal, Amir Mortazavi, Sumanta Pal, Rana R. McKay, Elaine T. Lam

“…Background: Metastatic renal cell carcinoma (mRCC) is a heterogenous disease with poor 5-year overall survival (OS) at 14%. Patients with mRCC to endocrine…”
Get full text

Correlation of digital health use and chronic pain coping strategies by Ranney, Megan L, Duarte, Cassandra, Baird, Janette, Patry, Emily J, Green, Traci C

“…Digital health is an increasingly popular tool for patient engagement, having shown great success in arenas such as medication adherence, management of chronic…”
Get full text

Abiraterone acetate to treat metastatic castration-resistant prostate cancer in combination with prednisone by Duarte, Cassandra, Jimeno, A, Kessler, E R

“…Prostate cancer is one of the most common cancers in the United States, with an estimated incidence of 164,690 cases, accounting for 9.5% of all new cancer…”
Get full text